The psychosocial impact of thyroid cancer.

Parker Haymart, Nina Jackson Levin, Megan R Haymart
Author Information
  1. Parker Haymart: Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine.
  2. Nina Jackson Levin: School of Social Work, Department of Anthropology, University of Michigan, Ann Arbor, Michigan, USA.
  3. Megan R Haymart: Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine.

Abstract

PURPOSE OF REVIEW: This review discusses the psychosocial impact of thyroid cancer diagnosis and management. It summarizes recent findings, presents management options, and briefly discusses future directions.
RECENT FINDINGS: A thyroid cancer diagnosis and its downstream management can impact patients in a variety of ways, including contributing to distress, worry, worse quality of life, and in some cases, anxiety and depression. Racial/ethnic minorities, those with lower education, women, adolescents/young adults, and individuals with a prior mental health conditions are a few of the patient groups at greater risks for adverse psychosocial effects from their thyroid cancer diagnosis and management. Findings are mixed, but some studies suggest treatment, for example, more intensive treatment as opposed to less, may be associated with a greater psychosocial impact. Clinicians providing care to thyroid cancer patients use a variety of resources and techniques, some more effective than others, to provide support.
SUMMARY: A thyroid cancer diagnosis and its subsequent treatment can greatly impact a patient's psychosocial wellbeing, particularly for at-risk groups. Clinicians can help their patients by informing them of the risks associated with treatments and by offering education and resources for psychosocial support.

References

  1. Cancer Control. 2021 Jan-Dec;28:10732748211029726 [PMID: 34189945]
  2. J Endocrinol Invest. 2023 Feb;46(2):319-326 [PMID: 35988109]
  3. Thyroid. 2021 Dec;31(12):1800-1807 [PMID: 34641715]
  4. Endocrinol Metab (Seoul). 2022 Aug;37(4):664-673 [PMID: 36065647]
  5. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  6. Support Care Cancer. 2022 Jan;30(1):687-693 [PMID: 34363111]
  7. J Cancer Surviv. 2013 Sep;7(3):300-22 [PMID: 23475398]
  8. Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):342-6 [PMID: 19380354]
  9. J Clin Endocrinol Metab. 2015 Mar;100(3):977-85 [PMID: 25393643]
  10. Hormones (Athens). 2013 Jul-Sep;12(3):428-38 [PMID: 24121384]
  11. Thyroid. 2013 Oct;23(10):1247-55 [PMID: 23578315]
  12. J Cancer Surviv. 2021 Jun;15(3):418-426 [PMID: 32939685]
  13. Health Qual Life Outcomes. 2010 Sep 15;8:101 [PMID: 20840792]
  14. JAMA Surg. 2022 Mar 01;157(3):200-209 [PMID: 34935859]
  15. World Psychiatry. 2009 Jun;8(2):91-2 [PMID: 19516930]
  16. Surgery. 2020 Jan;167(1):94-101 [PMID: 31623853]
  17. Endocrine. 2021 Dec;74(3):603-610 [PMID: 34143334]
  18. Thyroid. 2016 Sep;26(9):1239-50 [PMID: 27350421]
  19. Thyroid. 2019 Aug;29(8):1080-1088 [PMID: 31232194]
  20. Clin Endocrinol (Oxf). 2011 Oct;75(4):544-54 [PMID: 21615448]
  21. J Surg Res. 2018 Jun;226:94-99 [PMID: 29661295]
  22. Acta Oncol. 2013 Jan;52(1):128-37 [PMID: 23101467]
  23. World J Surg. 2022 Oct;46(10):2423-2432 [PMID: 35798990]
  24. Psychooncology. 2014 Aug;23(8):946-52 [PMID: 24619907]
  25. Thyroid. 2017 Feb;27(2):197-206 [PMID: 27824301]
  26. Cancer. 2020 Apr 1;126(7):1512-1521 [PMID: 31869452]
  27. Thyroid. 2022 Sep;32(9):1077-1085 [PMID: 35734910]
  28. Support Care Cancer. 2022 Nov;30(11):8959-8967 [PMID: 35922683]
  29. Endocrine. 2022 May;76(2):377-384 [PMID: 35113335]
  30. Surgery. 2019 Jul;166(1):69-74 [PMID: 30898373]
  31. Thyroid. 2015 Jun;25(6):649-56 [PMID: 25809716]
  32. J Clin Endocrinol Metab. 2020 Dec 1;105(12): [PMID: 32918085]
  33. Lancet. 2023 May 6;401(10387):1531-1544 [PMID: 37023783]
  34. Lancet Diabetes Endocrinol. 2022 Apr;10(4):264-272 [PMID: 35271818]
  35. Thyroid. 2018 Oct 26;: [PMID: 30244657]
  36. Endocr Connect. 2022 Feb 28;11(2): [PMID: 35107083]
  37. JAMA Otolaryngol Head Neck Surg. 2019 Mar 1;145(3):231-238 [PMID: 30653212]
  38. Thyroid. 2017 Aug;27(8):1034-1042 [PMID: 28474541]
  39. Surgery. 2020 Jan;167(1):102-109 [PMID: 31582311]
  40. Surgery. 2018 Nov;164(5):986-992 [PMID: 30149935]
  41. J Cancer Surviv. 2022 Apr;16(2):303-313 [PMID: 33728574]
  42. J Cancer Surviv. 2013 Dec;7(4):602-13 [PMID: 23918453]
  43. Thyroid. 2016 Jul;26(7):923-32 [PMID: 27161396]
  44. Head Neck. 2018 Oct;40(10):2235-2245 [PMID: 29756245]
  45. J Cancer Surviv. 2023 Oct;17(5):1359-1370 [PMID: 35318569]
  46. World J Surg. 2016 Mar;40(3):551-61 [PMID: 26546191]
  47. J Cancer Surviv. 2016 Aug;10(4):663-73 [PMID: 26782171]
  48. Sci Rep. 2020 Apr 1;10(1):5765 [PMID: 32238870]
  49. Curr Oncol. 2022 Jun 21;29(7):4386-4422 [PMID: 35877210]
  50. J Cancer Surviv. 2022 Aug;16(4):844-852 [PMID: 34633638]

Grants

  1. T32 CA236621/NCI NIH HHS

MeSH Term

Young Adult
Adolescent
Humans
Female
Quality of Life
Thyroid Neoplasms
Anxiety

Word Cloud

Created with Highcharts 10.0.0psychosocialthyroidcancerimpactdiagnosismanagementcanpatientstreatmentdiscussesvarietyeducationgroupsgreaterrisksassociatedCliniciansresourcessupportPURPOSEOFREVIEW:reviewsummarizesrecentfindingspresentsoptionsbrieflyfuturedirectionsRECENTFINDINGS:downstreamwaysincludingcontributingdistressworryworsequalitylifecasesanxietydepressionRacial/ethnicminoritieslowerwomenadolescents/youngadultsindividualspriormentalhealthconditionspatientadverseeffectsFindingsmixedstudiessuggestexampleintensiveopposedlessmayprovidingcareusetechniqueseffectiveothersprovideSUMMARY:subsequentgreatlypatient'swellbeingparticularlyat-riskhelpinformingtreatmentsoffering

Similar Articles

Cited By